DK2718725T3 - Procedure for the diagnosis of Gaucher's disease - Google Patents

Procedure for the diagnosis of Gaucher's disease Download PDF

Info

Publication number
DK2718725T3
DK2718725T3 DK12728976.7T DK12728976T DK2718725T3 DK 2718725 T3 DK2718725 T3 DK 2718725T3 DK 12728976 T DK12728976 T DK 12728976T DK 2718725 T3 DK2718725 T3 DK 2718725T3
Authority
DK
Denmark
Prior art keywords
sample
subject
disease
biomarker
level
Prior art date
Application number
DK12728976.7T
Other languages
Danish (da)
English (en)
Inventor
Arndt Rolfs
Hermann Mascher
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44652046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2718725(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centogene Ag filed Critical Centogene Ag
Application granted granted Critical
Publication of DK2718725T3 publication Critical patent/DK2718725T3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442Chitinase (3.2.1.14)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • G01N2405/10Glycosphingolipids, e.g. cerebrosides, gangliosides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK12728976.7T 2011-06-06 2012-06-06 Procedure for the diagnosis of Gaucher's disease DK2718725T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11004597A EP2533051A1 (en) 2011-06-06 2011-06-06 Method for the diagnosis of Gaucher's disease
PCT/EP2012/002409 WO2012167925A1 (en) 2011-06-06 2012-06-06 Method for the diagnosis of gaucher's disease

Publications (1)

Publication Number Publication Date
DK2718725T3 true DK2718725T3 (en) 2018-03-26

Family

ID=44652046

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12728976.7T DK2718725T3 (en) 2011-06-06 2012-06-06 Procedure for the diagnosis of Gaucher's disease
DK17206796.9T DK3318881T3 (da) 2011-06-06 2012-06-06 Fremgangsmåde til overvågning af Gaucher's sygdom

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17206796.9T DK3318881T3 (da) 2011-06-06 2012-06-06 Fremgangsmåde til overvågning af Gaucher's sygdom

Country Status (15)

Country Link
US (3) US10859580B2 (enExample)
EP (4) EP2533051A1 (enExample)
JP (2) JP6120832B2 (enExample)
CN (1) CN103582818B (enExample)
AU (2) AU2012266768B2 (enExample)
BR (1) BR112013031431B1 (enExample)
CA (1) CA2837609C (enExample)
DK (2) DK2718725T3 (enExample)
ES (2) ES2820361T3 (enExample)
IL (2) IL229607B (enExample)
NO (1) NO2718725T3 (enExample)
PL (2) PL2718725T3 (enExample)
PT (2) PT2718725T (enExample)
RU (1) RU2666952C2 (enExample)
WO (1) WO2012167925A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2932274B1 (en) * 2012-12-11 2020-01-15 Centogene AG Method for the diagnosis of metachromatic leukodystrophy
WO2015121855A1 (en) * 2014-02-11 2015-08-20 Yeda Research And Development Co. Ltd. Marker of neuropathic gaucher's disease and methods of use thereof
CN105463085A (zh) * 2015-12-11 2016-04-06 上海新培晶医学检验所有限公司 一种检测戈谢病gba基因突变的试剂盒及其检测方法
EP3264092A1 (en) 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
RU2629626C1 (ru) * 2016-10-05 2017-08-30 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ оценки эффективности лечения болезни Гоше у детей
KR20230129426A (ko) 2020-12-08 2023-09-08 토드 프랭크 오보케이티스 줄기 세포 생산 증가를 위한 방법 및 시스템
IL317112A (en) * 2022-06-01 2025-01-01 Univ Antwerpen Method for detecting biomarkers of lysosomal storage disease and kits for performing the method
WO2024211616A1 (en) * 2023-04-04 2024-10-10 Ovokaitys Todd Frank Methods and systems for improved therapies of genetic diseases using photo-activated allogenic stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236838A (en) 1988-12-23 1993-08-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
UA63743A (en) * 2003-06-09 2004-01-15 Kyiv P Shupyk Medical Academy Method for diagnosing gaucher disease
EP1528056A1 (en) 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
CN104771402A (zh) * 2005-06-08 2015-07-15 阿米库斯治疗学公司 溶酶体酶编码基因突变相关的cns紊乱的治疗
EP2040548B1 (en) * 2006-06-23 2012-05-02 Amicus Therapeutics, Inc. Method for the treatment of neurological disorders by enhancing the activity of beta -glucocerebrosidase
WO2008128106A1 (en) 2007-04-13 2008-10-23 Amicus Therapeutics, Inc. Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
WO2008134628A2 (en) * 2007-04-26 2008-11-06 Amicus Therapeutics, Inc. Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
HUE027278T2 (en) 2007-05-16 2016-11-28 Brigham & Womens Hospital Inc Treatment of synucleinopathies
CA2745451A1 (en) * 2008-11-14 2010-05-20 Parkinson's Institute Compositions and methods for the treatment of altered a-synuclein function

Also Published As

Publication number Publication date
CA2837609A1 (en) 2012-12-13
EP2533051A1 (en) 2012-12-12
EP2718725B1 (en) 2017-12-13
AU2017232226A1 (en) 2017-10-12
JP6120832B2 (ja) 2017-04-26
EP3742168A1 (en) 2020-11-25
EP2718725A1 (en) 2014-04-16
IL229607B (en) 2018-07-31
JP2017161528A (ja) 2017-09-14
AU2012266768B2 (en) 2017-06-29
RU2018129872A3 (enExample) 2021-11-08
PT3318881T (pt) 2020-09-16
EP3318881A1 (en) 2018-05-09
US10859580B2 (en) 2020-12-08
BR112013031431A2 (pt) 2016-12-13
US20180259538A1 (en) 2018-09-13
RU2013158667A (ru) 2015-07-20
CA2837609C (en) 2023-04-18
IL229607A0 (en) 2014-01-30
RU2666952C2 (ru) 2018-09-13
PT2718725T (pt) 2018-03-07
PL3318881T3 (pl) 2021-02-08
EP3318881B1 (en) 2020-07-15
US20220011321A1 (en) 2022-01-13
NO2718725T3 (enExample) 2018-05-12
DK3318881T3 (da) 2020-09-28
IL260078A (en) 2018-07-31
WO2012167925A1 (en) 2012-12-13
CN103582818B (zh) 2018-06-05
JP6514256B2 (ja) 2019-05-15
US20140187439A1 (en) 2014-07-03
BR112013031431B1 (pt) 2023-02-07
IL260078B (en) 2020-10-29
RU2018129872A (ru) 2019-03-15
ES2659753T3 (es) 2018-03-19
US11092609B2 (en) 2021-08-17
CN103582818A (zh) 2014-02-12
JP2014517308A (ja) 2014-07-17
PL2718725T3 (pl) 2018-06-29
AU2017232226B2 (en) 2019-12-19
ES2820361T3 (es) 2021-04-20

Similar Documents

Publication Publication Date Title
US11092609B2 (en) Method for the diagnosis of Gaucher's disease
US11841362B2 (en) Method for the diagnosis of Niemann-Pick disease
AU2012266768A1 (en) Method for the diagnosis of Gaucher's disease
EP2997384B1 (en) Method for the diagnosis of niemann-pick disease
US20180348239A1 (en) Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
HK40033027A (en) Biomarker for gaucher's disease
RU2780331C2 (ru) Способ диагностики болезни гоше